Moreover, the level of CA15-3 was significantly higher in breast cancer patients compared to healthy-matched controls based on our data, and this high level positively correlated with patients’ ages and tumor sizes, as well as the presence of p53 and lymph and vascular invasion. This evidence concerns the gene TP53 and breast cancer.